Granulocyte-macrophage colony-stimulating factor gene-modified vaccines for immunotherapy of cancer.
Bubeník
J
J
Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague.
D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use*; D015316:Genetic Therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D016233:Immunotherapy, Active; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008819:Mice, Nude; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D051381:Rats; D012513:Sarcoma, Experimental / Q000628:therapy; D014407:Tumor Cells, Cultured / Q000637:transplantation; D019444:Vaccines, DNA / Q000627:therapeutic use*
D019496:Cancer Vaccines; D019444:Vaccines, DNA; D016178:Granulocyte-Macrophage Colony-Stimulating Factor